Contribution of the vagus nerve to angiotensin II binding sites in the canine medulla.
Specific angiotensin II (Ang II) binding sites are present in the dorsal medulla of several species, and dose-related cardiovascular effects are produced by microinjection of the peptide into this region. Because the anatomical location of Ang II binding sites in the area postrema (ap), nucleus tractus solitarii (nTS), and dorsal motor nucleus of the vagus (dmnX) coincides with the topography of vagal afferent fibers and efferent motor neurons, the effect of either nodose ganglionectomy or cervical vagotomy on Ang II binding sites in the dorsomedial medulla was investigated in dogs by in vitro receptor autoradiography. Two weeks after unilateral ganglionectomy, there was a marked reduction in the density of specific Ang II binding sites in the ipsilateral ap, nTS, and dmnX, and an absence of binding sites in the region where vagal afferent fibers course through the rostral medulla. Unilateral cervical vagotomy, which has been shown to spare central processes of afferent fibers, resulted in a loss of binding only in the ipsilateral dmnX. We also show that Ang II binding sites are present in the nodose ganglion and central and peripheral processes of the vagus nerve. The data indicate that medullary Ang II binding sites are associated with both vagal afferent fibers and efferent motor neurons.
D000804:Angiotensin II / Q000378:metabolism; D000818:Animals; D001345:Autoradiography; D004285:Dogs; D008297:Male; D008526:Medulla Oblongata / Q000378:metabolism*; D009620:Nodose Ganglion / Q000502:physiology*; D011945:Receptors, Angiotensin / Q000378:metabolism*; D014630:Vagus Nerve / Q000502:physiology*
D011945:Receptors, Angiotensin; D000804:Angiotensin II